Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonmetastatic Castration-Resistant Prostate Cancer”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableStudy completedNCT06204302
What this trial is testing

An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States

Who this might be right for
Non-metastatic Prostate CancerNon-metastatic Castration-resistant Prostate Cancer
Bayer 1,800
Testing effectiveness (Phase 2)Study completedNCT01046916
What this trial is testing

Safety and Efficacy Study of TAK-700 in Patients With Nonmetastatic Castration-resistant Prostate Cancer and a Rising Prostate-specific Antigen

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 38
Large-scale testing (Phase 3)Study completedNCT02003924
What this trial is testing

Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

Who this might be right for
Nonmetastatic Castration-Resistant Prostate CancerProstate CancerCancer of the Prostate
Pfizer 1,401
Testing effectiveness (Phase 2)Study completedNCT05171387
What this trial is testing

Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Bayer 78
Early research (Phase 1)Study completedNCT00305747
What this trial is testing

Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 12
Testing effectiveness (Phase 2)WithdrawnNCT01087580
What this trial is testing

Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer

Who this might be right for
PROSTATE CANCER
Northwestern University